Blinded Envudeucitinib clinical trials

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

This study looks at how safe and effective a new medicine, ESK-001, is for people with moderate to severe plaque psoriasis over a long time. It builds on previous studies and carefully watches patients who continue treatment.